PharmD Bcop J. Michael Vozniak

Drug-Drug Interactions, Safety, and Pharmacokinetics of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non–Small Cell Lung Cancer

Dnp Crnp Colleen R. Kucharczuk, PharmD Bcop Alex Ganetsky, PharmD Bcop J. Michael Vozniak, 2018, Journal of the advanced practitioner in oncology.